Back to today’s briefing

Story perspectives

FDA Approves AI Urine Test for Bladder Cancer Screening

7/4/2025

50 10

Summary

Story summary

The FDA has given a significant boost to the fight against bladder cancer by granting breakthrough device designation to the TOBY Test, an innovative AI-powered urine test. This non-invasive solution promises to ease the discomfort of traditional cystoscopy while tackling the high recurrence rates of the disease, paving the way for better access to vital cancer screenings.

1 of 1

Story summary

The FDA has given a significant boost to the fight against bladder cancer by granting breakthrough device designation to the TOBY Test, an innovative AI-powered urine test. This non-invasive solution promises to ease the discomfort of traditional cystoscopy while tackling the high recurrence rates of the disease, paving the way for better access to vital cancer screenings.